Utah Medical Products, Inc.
UTMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $41 | $50 | $52 | $49 |
| % Growth | -18.6% | -3.9% | 6.6% | – |
| Cost of Goods Sold | $17 | $20 | $20 | $18 |
| Gross Profit | $24 | $30 | $32 | $31 |
| % Margin | 59% | 59.8% | 61.6% | 63% |
| R&D Expenses | $1 | $1 | $0 | $1 |
| G&A Expenses | $4 | $11 | $10 | $10 |
| SG&A Expenses | $6 | $13 | $12 | $12 |
| Sales & Mktg Exp. | $2 | $2 | $2 | $1 |
| Other Operating Expenses | $4 | $0 | $0 | $0 |
| Operating Expenses | $11 | $13 | $12 | $12 |
| Operating Income | $14 | $17 | $20 | $19 |
| % Margin | 33.2% | 33.4% | 37.9% | 38.5% |
| Other Income/Exp. Net | $3 | $3 | $1 | $0 |
| Pre-Tax Income | $17 | $20 | $21 | $19 |
| Tax Expense | $3 | $3 | $4 | $4 |
| Net Income | $14 | $17 | $16 | $15 |
| % Margin | 33.9% | 33.1% | 31.5% | 30.1% |
| EPS | 3.96 | 4.57 | 4.53 | 4.05 |
| % Growth | -13.3% | 0.9% | 11.9% | – |
| EPS Diluted | 3.96 | 4.57 | 4.52 | 4.04 |
| Weighted Avg Shares Out | 4 | 4 | 4 | 4 |
| Weighted Avg Shares Out Dil | 4 | 4 | 4 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $0 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $6 | $7 | $7 |
| EBITDA | $16 | $25 | $27 | $26 |
| % Margin | 40.2% | 49.3% | 51.4% | 53.3% |